Onderneming Cipher Pharmaceuticals Inc Nasdaq
Aandelen
CA17253X1050
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Specialty Pharmaceuticals
100,0
%
| 27 | 100,0 % | 29 | 100,0 % | +6,12% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
60,0
%
| 16 | 60,0 % | 17 | 60,0 % | +6,12% |
United States
40,0
%
| 11 | 40,0 % | 11 | 40,0 % | +6,12% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 26-03-19 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 15-08-22 |
James Bowen
IRC | Investor Relations Contact | - | - |
Emilio Presti
SAM | Sales & Marketing | - | - |
Diane Gajewczyk
PRN | Corporate Officer/Principal | - | 05-06-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 08-08-16 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 21-06-23 |
Craig Mull
CEO | Chief Executive Officer | - | 26-03-19 |
Hubert Walinski
BRD | Director/Board Member | - | 21-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 24 112 843 | 13 271 046 ( 55,04 %) | 0 | 55,04 % |
Bedrijfsgegevens
Cipher Pharmaceuticals, Inc.
5750 Explorer Drive Suite 404
L4W 0A9, Mississauga
+905-602-5840
http://www.cipherpharma.com![Adres Cipher Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/19343861.png)
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+50,70% | 795 mld. | |
+41,96% | 627 mld. | |
-7,15% | 350 mld. | |
+18,77% | 328 mld. | |
+8,79% | 294 mld. | |
+18,02% | 245 mld. | |
+1,27% | 222 mld. | |
+11,95% | 215 mld. | |
+3,68% | 160 mld. |